期刊文献+

血脑屏障上P-糖蛋白研究进展

Advances on P-glycoprotein at blood-brain barrier
下载PDF
导出
摘要 P-糖蛋白是血脑屏障上一种重要的物质外排生物转运体,参与人体多种生理病理过程,并能改变一些药物脑内动力学行为。本文综述了近年来国内外关于血脑屏障上P-糖蛋白研究的新进展,这对于认识某些中枢系统疾病、设计其治疗方案,以及开发新型P-糖蛋白调节剂都具有重要的指导意义。 P-glycoprotein is an important drug efflux transporter at the blood-brain barrier. It is involved in various physiological and pathological processes in the body and can change the kinetic behavior of drugs in the brain. This article reviews the recent advances of P-glycoprotein on the blood-brain barrier, which is helpful for us to understand some diseases of the central nervous system, devise their therapeutic regimens and develop new regulator of P-glycoprotein.
出处 《神经科学通报》 CSCD 2005年第5期351-355,共5页 Neuroscience Bulletin
关键词 P-糖蛋白 血脑屏障 转运体 多药耐药 P-glycoprotein blood-brain barrier transporter multidrug resistance
  • 相关文献

参考文献23

  • 1Demeule M, Jodoin J, Gingras D et al. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett,2000,466:219-224.
  • 2Schinkel AH, Wagenaar E, van Deemter L, et al. Absence of the mdrla P-Glycoprotein in mice 'affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest, 1995,96 (4) : 1698-1705.
  • 3Smit JJ, Schinkel AH, Oude-Elferink RP, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 1993,75(3) :451 -462.
  • 4Letrent SP, Pollack GM, Brouwer KR, et al. Effect of a potent and specific P-glycoprotein inhibitor on the blood-brain ban'ier distribution and antinociceptive effect of morphin in the rat. Drug Metab Dispos, 1999,27 ( 7 ) : 827-834.
  • 5Potschka H, Loscher W. bt vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain banier of rats. Epilepsia, 2001,42(10) : 1231-1240.
  • 6van der Sandt ICJ, Smolders R, Nalbusi L, zt al. Active efflux of the 5-HT1A receptor antagonist fiesinoxan via P-glycoprotein at the blood-brain barrier. Eur J Pharm Sci,2001,14:81-86.
  • 7Jonker JW, Wagenaar E, Van Deemter L, et al. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Br J Pharmacol, 1999,127:43-50.
  • 8Chishty M, Reichel A, Siva J, et al. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modem antihistamines. J Drug Target, 2001,93 :223-228.
  • 9Tardieu M. HIV-1 related central nervous system diseases. Curr Opin Neurol, 1999,12(4) :377-381.
  • 10Matheny CJ, Lamb MW, Brower KR, et al. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Pharmacotherapy, 2001,21 (7) :778-796.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部